Expert Medical Monitoring Services in Clinical Trials That Reduce Risk and Delays
Oversight by medical experts is a critical component of clinical trials—ensuring ethical standards are upheld, clinical risks are managed, therapeutic insights are applied, and the well-being of study participants remains the top priority. At Allucent, the Medical Affairs team plays a pivotal role in advancing clinical studies, contributing from early development through to product approval and beyond. As part of our collaborative approach, we provide strategic input across all phases, including support for clinical monitoring services and leadership in medical monitoring clinical research, both of which are essential to maintaining trial integrity and participant safety. Our team is composed of experienced physicians and scientists specializing in clinical research and drug safety across a wide range of indications and therapeutic areas—including oncology, neurosciences, immunology and vaccines, allergies, cell and gene therapies, pediatrics, and rare diseases.
“My team brings deep experience across numerous therapeutic areas and has a profound understanding of both local regulations and global market trends. This enables us to support a wide range of projects, from early-stage clinical trials to post-marketing pharmacovigilance.”
Teresa Nunes, MD
Chief Medical Officer
